Ftse Mib
34.208,80
-0,49%
DAX
18.499,69
-0,54%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.150,00
-2,62%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
06/07/202012:00GlobeNewswire Inc.Applied Therapeutics Takes Action Against Fraudulent “Short Report”NASDAQ:APLTApplied Therapeutics Inc
16/06/202012:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APLTApplied Therapeutics Inc
15/06/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Start of AT-007 Pediatric Galactosemia Study; Releases Additional 40mg/kg Data from Adult Gala...NASDAQ:APLTApplied Therapeutics Inc
12/06/202022:53Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:APLTApplied Therapeutics Inc
08/06/202013:00GlobeNewswire Inc.Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Associa...NASDAQ:APLTApplied Therapeutics Inc
06/06/202000:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
05/06/202022:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
05/06/202012:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:APLTApplied Therapeutics Inc
05/06/202012:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:APLTApplied Therapeutics Inc
03/06/202013:00GlobeNewswire Inc.Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
01/06/202023:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
27/05/202000:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APLTApplied Therapeutics Inc
26/05/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Busi...NASDAQ:APLTApplied Therapeutics Inc
12/05/202013:00GlobeNewswire Inc.Applied Therapeutics to Present at the UBS Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
11/05/202013:49Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APLTApplied Therapeutics Inc
11/05/202013:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
11/05/202013:00GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2020 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
23/04/202015:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APLTApplied Therapeutics Inc
23/04/202015:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APLTApplied Therapeutics Inc
21/04/202013:00GlobeNewswire Inc.Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia TrialNASDAQ:APLTApplied Therapeutics Inc
02/04/202013:00GlobeNewswire Inc.Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 PatientsNASDAQ:APLTApplied Therapeutics Inc
13/03/202015:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APLTApplied Therapeutics Inc
13/03/202012:00GlobeNewswire Inc.Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
10/03/202012:00GlobeNewswire Inc.Applied Therapeutics to Present at the Barclays Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
03/03/202013:00GlobeNewswire Inc.Applied Therapeutics Appoints Adam Hansard as Chief Commercial OfficerNASDAQ:APLTApplied Therapeutics Inc
26/02/202022:05GlobeNewswire Inc.Applied Therapeutics to Present at the Cowen and Company 40th Annual Health Care ConferenceNASDAQ:APLTApplied Therapeutics Inc
15/02/202007:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
14/02/202023:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APLTApplied Therapeutics Inc
14/02/202014:16Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:APLTApplied Therapeutics Inc
28/01/202018:24GlobeNewswire Inc.Applied Therapeutics, Inc. Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchas...NASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

NASDAQ
CPAAW
Conyers Park III Acquisi...
LSE
100H
Am Ftse100 Usdh
TSXV
GBR
Great Bear Resources
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network